Viola Bagóné Vántus

5PUBLICATIONS
23CO-AUTHORS
Medical mycologyMetabolic medicineCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 27, 2026
Selective MIF Enolase Inhibitor TE-91 Regulates M1 Polarization and Associated Metabolic Reprogramming.

|Sep 28, 2024
Comparison of Mitochondrial and Antineoplastic Effects of Amiodarone and Desethylamiodarone in MDA-MB-231 Cancer Line.

Fadi H J Ramadan, Balazs Koszegi, Viola B Vantus

|Sep 27, 2021
Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn's Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells.

Dominika Kovács, Viola Bagóné Vántus, Eszter Vámos

|Jul 06, 2021
Tetralone derivatives are MIF tautomerase inhibitors and attenuate macrophage activation and amplify the hypothermic response in endotoxemic mice.

János Garai, Marcell Krekó, László Őrfi

|Mar 06, 2021
Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells.

Kitti Andreidesz, Balazs Koszegi, Dominika Kovacs

Pageof 1

Frequent Collaborators

3 joint publications

Ferenc Gallyas

3 joint publications

Balázs Radnai

3 joint publications

Eszter Vámos

2 joint publications

Tamás Lóránd